Sangamo Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for SGMO, updated each market day.
SGMO AI Sentiment
AI predicts Sangamo Therapeutics, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Sangamo Therapeutics, Inc. Common Stock
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its neurology development is focused on two areas: development of epigenetic regulation therapies to treat serious neurological diseases and development of novel engineered adeno-associated virus, or AAV, capsids to deliver its therapies to the intended neurological targets. The group's pipeline products are Small Fiber Neuropathy, Prion Disease, Tauopathies, ALS/FTD, Huntington's Disease, Fabry Disease, and Hemophilia A.
Sector
Exchange
Market Cap
$108,498,365
Cap Tier
Employees
142
Headquarters
RICHMOND, CA
Listed Since
April 6, 2000
Website
SGMO Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
SGMO Volatility
Sangamo Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
